tiprankstipranks

Processa sells 28M shares at 25c in public offering

Processa Pharmaceuticals (PCSA) announced the pricing of a public offering of 28M shares of common stock at a public offering price of 25c per share. The closing of the offering is expected to occur on or about June 18. H.C. Wainwright is acting as the exclusive placement agent for the offering. The gross proceeds to the Company from the offering are expected to be $7M. Processa intends to use the net proceeds from the offering to continue the Phase 2 clinical trial for NCG-Cap.

Don’t Miss TipRanks’ Half-Year Sale

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1